INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

DAFNA Capital Management LLC's Holding History (CIK: 0001389933)

Note: Option positions (PUT/CALL) are excluded.

Q3 2015
Shares 2,430 Value ($000) $403 Avg Close — Range —
Q2 2015
Shares 2,000 Value ($000) $483 Avg Close — Range —
Q1 2015
Shares 2,000 Value ($000) $564 Avg Close — Range —
Q4 2014
Shares 21,900 Value ($000) $3,416 Avg Close — Range —
Q3 2014
Shares 2,000 Value ($000) $473 Avg Close — Range —
Q2 2014
Shares 2,000 Value ($000) $473 Avg Close — Range —
Q1 2014
Shares 2,000 Value ($000) $660 Avg Close — Range —
Q4 2013
Shares 9,598 Value ($000) $655 Avg Close — Range —
Q3 2013
Shares 9,598 Value ($000) $663 Avg Close — Range —
Q2 2013
Shares 10,000 Value ($000) $448 Avg Close — Range —